Out now! Proud to have represented Pancreas Verona in this outstanding manuscript from the The PRECEDE Consortium Study we are part of, published on Journal of the @NCCN. So many efforts on #PancreaticCancer early detection. Diane M. Simeone, MD AISP Fondazione Nadia Valsecchi Onlus

📣Out now! The path leading to the creation of a registry of individuals at risk of pancreatic cancer in a universal health care system: origins and future perspectives. Thanks to all who contributed! Pancreas Verona AISP Gabriele Capurso MD, PhD🇺🇦 Livia Archibugi Fondazione Nadia Valsecchi Onlus

👀 Open position for an MD at Pancreas Verona

🎯 Research project on AI models in pancreatic disease

univr.it/en/job-vacanci…
Roberto Salvia Università di Verona

👉🏾Prospective study on PROMs and QOL after PD at 5 time points
👉🏾Adj Chemo and post-op complications did not affect QoL
👉🏾General QoL and health were PROMs rated as ‘very important'
👉🏾QoL measures return to baseline at 6-months postop
@HPBjournal shorturl.at/amE04

esectable #PancreaticCancer : chemo + surgery or surgery + chemo? In both cases, 25% of patients will not complete the multimodal treatment. Patient selection and multidisciplinary decisions are the key. Our point of view rdcu.be/dyzPp
AnnalsSurgOncology Pancreas Verona

🔥🔥off the press! Contemporary analysis of resection rates, reasons for intraoperative attrition, and survival outcomes in the entire spectrum of PDAC patients selected for surgical exploration (upfront and post-treatment) journals.lww.com/annalsofsurger…

Here you can find everything you need to know when you approach #PrecisionOncology .

Simple & accessible format with tips from incredible experts in the field (thanks to all co-authors!)

Thanks to CA: A Cancer Journal for Clinicians for the opportunity to disseminate our guidance.

Enjoy it!🙂

Facciamo rumore sul #tumore al #pancreas e raggiungiamo i soggetti a rischio da sorvegliare! 💪💪 AISP Ministero della Salute Ministero dell'Università e della Ricerca Regione del Veneto

Roberto Salvia Tribute to Claudio Bassi at the IHPBA 2024 World Conference. Visit ihpba2024.org to see all our speakers.E-AHPBA AHPBA #IHPBA24 Roberto Salvia

🟣 The PRECEDE Meeting is an annual outstanding event 🟣 Many ideas in the box and brilliant scientists thinking out of the box 🟣 Pancreatic cancer early detection will pass through here! 🕊️🤞🙏PrecedeStudy Fondazione Nadia Valsecchi Onlus Project Purple® Pancreas Verona Diane M. Simeone, MD Università di Verona

Pubblicato su AJG - The American Journal of Gastroenterology lo studio dedicato alla memoria di Massimo Canonica 🙏

Dopo la diagnosi di tumore al pancreas, Massimo è salito in bici ed ha percorso centinaia di km per la ricerca 🚵‍♀️

Questo studio dimostra la validità del programma di screening su soggetti a rischio

Productive day at #UEGWeek2023 for EPC-Europ Pancr Club, starting with EPC Council meeting and moving on with #PEI #guidelines meeting.

Therapeutic developments in #PancreaticCancer
nature.com/articles/s4157…
In Nature Reviews Gastroenterology & Hepatology by Eileen M O’Reilly Memorial Sloan Kettering Cancer Center

Out now the 3-year results of the Italian Registry of PDAC Surveillance: a multicenter (18🏥) effort: 8 PDAC, 1 PanIN3, and 1-, 2- and 3-year cum haz of 1.7%, 2.5% and 3%📈. Thanks all🙏AISP Gabriele Capurso MD, PhD🇺🇦 EPC-Europ Pancr Club Pancreas Verona The PRECEDE Consortium Study E-AHPBA Fondazione Nadia Valsecchi Onlus

#OpenAccess review by Dr. Talia Golan & colleagues
Germline BRCA testing in #PancreaticCancer : improving awareness, timing, turnaround, and uptake
journals.sagepub.com/doi/10.1177/17…
(L) Barriers to germline BRCA testing in pancreatic cancer
(R) Alternative genetic services models

Low-yield surgery during pancreatic cancer surveillance: prevention or overtreatment? Definitely a thin border! A prevalence metanalysis. Check this out! Pancreas Verona Gabriele Capurso MD, PhD🇺🇦 Diane M. Simeone, MD Kasper.Overbeek James Farrell Giuseppe Malleo The PRECEDE Consortium Study IHPBA E-AHPBA my_UEG